We are making a handful of trades on Wednesday. We're buying 30 shares of Capital One Financial at roughly $208 each, increasing the weighting in Jim Cramer's Charitable Trust to 3.05% from 2.9% and ...

FDA on Friday said it would restrict GLP-1 ingredients Novo, Lilly shares fell after Hims launched the pill on Thursday Hims said the decision followed discussions with stakeholders "Since launching ...

United States Immigration and Customs Enforcement is leveraging Palantir’s generative artificial intelligence tools to sort and summarize immigration enforcement tips from its public submission form, ...

GLP-1 agonist medications (Ozempic and Wegovy) and dual GIP/GLP-1 receptor agonist medications (Zepbound and Mounjoaro) are powerful tools for weight loss, but losing weight rapidly can also lead the ...

For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...

In this photo, Humana chief executive officer Jim Rechtin speaks at the Forbes Healthcare Summit December 4, 2025 at NYU Langone Health in New York in an appearance with the entrepreneur Mark Cuban on ...

Influencer Samantha Milton has lost 260 pounds with the help of GLP-1 — and she’s ready to share her story. Milton, who is known on social media as “Smaller Sam PCOS,” told People in a Monday, January ...

The icon, who has cowritten a new book on obesity, tells PEOPLE she 'tried to beat the medication' Jamie Green In 2023, Oprah Winfrey revealed that she was taking GLP-1 weight loss medication, telling ...

is editor-in-chief of The Verge, host of the Decoder podcast, and co-host of The Vergecast. Today, I’m talking with Prashanth Chandrasekar, who is the CEO of Stack Overflow. I last had Prashanth on ...

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to a new KFF Health Tracking Poll. The poll also found that cost and side ...